Ingredient or product comparison
Cosmetic Peptides GHK-Cu Snap-8 Rejuvenate Skin: Combination vs Monotherapy
Mechanism Collagen upregulation via TGF-β pathway Neurotransmitter inhibition at SNARE complex Dual: structural + neuromodulatory Combined formulation targets both static and dynamic wrinkles. Addresses root causes Molecular Weight 340 Da 1,000 Da Both (requir
This source-based comparison does not add ratings or recommend a winner.
- Mechanism
- Collagen upregulation via TGF-β pathway
- Neurotransmitter inhibition at SNARE complex
- Dual: structural + neuromodulatory
- Combined formulation targets both static and dynamic wrinkles. Addresses root causes
- Molecular Weight
- 340 Da
- 1,000 Da
- Both (requires vehicle optimization)
- GHK-Cu penetrates more readily; Snap-8 requires penetration enhancers to reach viable epidermis
- Clinical Onset
- 8–12 weeks for collagen deposition
- 2–4 weeks for expression line reduction
- 2–4 weeks (Snap-8) + 8–12 weeks (GHK-Cu)
- Snap-8 provides early visible improvement; GHK-Cu delivers sustained structural change
- Effect Duration
- Persists 4–6 weeks post-discontinuation
- Baseline return within 14 days
- Snap-8 effect reverses; collagen gains persist longer
- Combination therapy requires continuous use for neuromodulatory effect
- Ideal Use Case
- Photoaged skin, loss of dermal density
- Forehead lines, crow's feet, frown lines
- Comprehensive facial aging (volume + expression)
- Monotherapy appropriate for targeted concern; combination for multi-mechanism intervention